Loading…
miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway
Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including metastasis. Our previous studies revealed that miR-25 promoted non-small-cell lung cancer (NSCLC) cell...
Saved in:
Published in: | Oxidative medicine and cellular longevity 2019, Vol.2019 (2019), p.1-14 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823 |
---|---|
cites | cdi_FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823 |
container_end_page | 14 |
container_issue | 2019 |
container_start_page | 1 |
container_title | Oxidative medicine and cellular longevity |
container_volume | 2019 |
creator | Ning, Yong Li, Yong Lu, Zhongxin Yan, Ge Zheng, Chao Liu, Shuiyi Li, Xiaoyi Jiang, Liyuan Zhang, Tianzhu Hu, Hui Wu, Tangwei Chen, Weiqun |
description | Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including metastasis. Our previous studies revealed that miR-25 promoted non-small-cell lung cancer (NSCLC) cell proliferation and suppressed cell apoptosis by directly targeting TP53 and MOAP1. In this work, we further explored the miR-25 expression in NSCLC patients in the Cancer Genome Atlas (TCGA) database and measured the miR-25 expression levels in the tissues of NSCLC patients and cell lines. miR-25 was overexpressed in both NSCLC tissues and cell lines. NSCLC patients who expressed a higher level of miR-25 exhibited worse overall survival than those with a lower level of miR-25. Overexpression of miR-25 enhanced NSCLC cell migration and invasion, while the inhibition of miR-25 exhibited the opposite effects. We identified the large tumor suppressor homology 2 (LATS2) as a new target gene of miR-25 in lung cancer. The effects of miR-25 on promoting NSCLC cell migration and invasion were at least partially due to activation of the Hippo signaling pathway. Additionally, miR-25 antagomir inhibited xenograft tumor growth and metastasis by the upregulation of LATS2. Taken together, our findings demonstrate that miR-25 contribute to lung cancer cell proliferation and metastasis by targeting the LATS2/YAP signaling pathway, which implicate miR-25 as a promising therapeutic target for lung cancer metastasis. Given that oxidative stress induces the overexpression of miR-25 and plays a critical role in cancer progression, this study establishes miR-25 as an intermediate between oxidative stress and lung cancer metastasis. |
doi_str_mv | 10.1155/2019/9719723 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6604298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A603153388</galeid><sourcerecordid>A603153388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823</originalsourceid><addsrcrecordid>eNqNks9v0zAUxyMEYlvhxhlZ4oLEQv0jTuLLpKpiMKlARcuBk_XqOKmnxB52sqn_AH83ztp1wImT33v--Pv8tV-SvCL4PSGcTykmYioKIgrKniSnRGQ0xUJkT48xxifJWQjXGOeMZuR5csIII3nkT5NfnfmWUo6W3nWu1wHNdduOWWtq7aE3zp6jz6Z5CMFW6MreQogZcjX64my66qBt0_uDi8E2aA5WaY82O7QG3-jexFq_1WgxW6_o9MdsiVamsdCO9SX02zvYvUie1dAG_fKwTpLvlx_W80_p4uvHq_lskapMiD6FHLBighCMs5qUpd7QrNRVlVFFSthwTkWh8lyJkmlVcFaVGRCywRwrXKmSsklysde9GTadrpS2vYdW3njTgd9JB0b-vWPNVjbuVuY5zmiUnSRvDwLe_Rx06GVngorWwWo3BEkpFwIXvMgi-uYf9NoNPvq-pzBnXOTskWqg1dLY2sW-ahSVsxwzwhkrx7bne0p5F4LX9fHKBMtxDOQ4BvIwBhF__afNI_zw7xF4twe2xlZwZ_5TTkdG1_BIUzw-DPsNoiXBqw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2250535963</pqid></control><display><type>article</type><title>miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway</title><source>Wiley Online Library website</source><source>Publicly Available Content (ProQuest)</source><creator>Ning, Yong ; Li, Yong ; Lu, Zhongxin ; Yan, Ge ; Zheng, Chao ; Liu, Shuiyi ; Li, Xiaoyi ; Jiang, Liyuan ; Zhang, Tianzhu ; Hu, Hui ; Wu, Tangwei ; Chen, Weiqun</creator><contributor>Moorthy, Bhagavatula ; Bhagavatula Moorthy</contributor><creatorcontrib>Ning, Yong ; Li, Yong ; Lu, Zhongxin ; Yan, Ge ; Zheng, Chao ; Liu, Shuiyi ; Li, Xiaoyi ; Jiang, Liyuan ; Zhang, Tianzhu ; Hu, Hui ; Wu, Tangwei ; Chen, Weiqun ; Moorthy, Bhagavatula ; Bhagavatula Moorthy</creatorcontrib><description>Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including metastasis. Our previous studies revealed that miR-25 promoted non-small-cell lung cancer (NSCLC) cell proliferation and suppressed cell apoptosis by directly targeting TP53 and MOAP1. In this work, we further explored the miR-25 expression in NSCLC patients in the Cancer Genome Atlas (TCGA) database and measured the miR-25 expression levels in the tissues of NSCLC patients and cell lines. miR-25 was overexpressed in both NSCLC tissues and cell lines. NSCLC patients who expressed a higher level of miR-25 exhibited worse overall survival than those with a lower level of miR-25. Overexpression of miR-25 enhanced NSCLC cell migration and invasion, while the inhibition of miR-25 exhibited the opposite effects. We identified the large tumor suppressor homology 2 (LATS2) as a new target gene of miR-25 in lung cancer. The effects of miR-25 on promoting NSCLC cell migration and invasion were at least partially due to activation of the Hippo signaling pathway. Additionally, miR-25 antagomir inhibited xenograft tumor growth and metastasis by the upregulation of LATS2. Taken together, our findings demonstrate that miR-25 contribute to lung cancer cell proliferation and metastasis by targeting the LATS2/YAP signaling pathway, which implicate miR-25 as a promising therapeutic target for lung cancer metastasis. Given that oxidative stress induces the overexpression of miR-25 and plays a critical role in cancer progression, this study establishes miR-25 as an intermediate between oxidative stress and lung cancer metastasis.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2019/9719723</identifier><identifier>PMID: 31316723</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adaptor Proteins, Signal Transducing - genetics ; Adaptor Proteins, Signal Transducing - metabolism ; Apoptosis ; Biomarkers ; Cancer ; Cancer therapies ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - metabolism ; Carcinoma, Non-Small-Cell Lung - pathology ; Cell cycle ; Cell growth ; Cell Line, Tumor ; Cell Proliferation - genetics ; Cell Proliferation - physiology ; China ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genetic aspects ; Genomes ; Health aspects ; Humans ; Kinases ; Lung cancer ; Lung cancer, Non-small cell ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Lung Neoplasms - pathology ; Medical prognosis ; Metastasis ; MicroRNA ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Mortality ; Oxidative stress ; Pathogenesis ; Prostate ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Signal Transduction ; Survival analysis ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Tumor proteins ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism</subject><ispartof>Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-14</ispartof><rights>Copyright © 2019 Tangwei Wu et al.</rights><rights>COPYRIGHT 2019 John Wiley & Sons, Inc.</rights><rights>Copyright © 2019 Tangwei Wu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2019 Tangwei Wu et al. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823</citedby><cites>FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823</cites><orcidid>0000-0001-8838-1714 ; 0000-0002-4628-2117 ; 0000-0002-3365-0881</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2250535963/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2250535963?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,4024,25753,27923,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31316723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Moorthy, Bhagavatula</contributor><contributor>Bhagavatula Moorthy</contributor><creatorcontrib>Ning, Yong</creatorcontrib><creatorcontrib>Li, Yong</creatorcontrib><creatorcontrib>Lu, Zhongxin</creatorcontrib><creatorcontrib>Yan, Ge</creatorcontrib><creatorcontrib>Zheng, Chao</creatorcontrib><creatorcontrib>Liu, Shuiyi</creatorcontrib><creatorcontrib>Li, Xiaoyi</creatorcontrib><creatorcontrib>Jiang, Liyuan</creatorcontrib><creatorcontrib>Zhang, Tianzhu</creatorcontrib><creatorcontrib>Hu, Hui</creatorcontrib><creatorcontrib>Wu, Tangwei</creatorcontrib><creatorcontrib>Chen, Weiqun</creatorcontrib><title>miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including metastasis. Our previous studies revealed that miR-25 promoted non-small-cell lung cancer (NSCLC) cell proliferation and suppressed cell apoptosis by directly targeting TP53 and MOAP1. In this work, we further explored the miR-25 expression in NSCLC patients in the Cancer Genome Atlas (TCGA) database and measured the miR-25 expression levels in the tissues of NSCLC patients and cell lines. miR-25 was overexpressed in both NSCLC tissues and cell lines. NSCLC patients who expressed a higher level of miR-25 exhibited worse overall survival than those with a lower level of miR-25. Overexpression of miR-25 enhanced NSCLC cell migration and invasion, while the inhibition of miR-25 exhibited the opposite effects. We identified the large tumor suppressor homology 2 (LATS2) as a new target gene of miR-25 in lung cancer. The effects of miR-25 on promoting NSCLC cell migration and invasion were at least partially due to activation of the Hippo signaling pathway. Additionally, miR-25 antagomir inhibited xenograft tumor growth and metastasis by the upregulation of LATS2. Taken together, our findings demonstrate that miR-25 contribute to lung cancer cell proliferation and metastasis by targeting the LATS2/YAP signaling pathway, which implicate miR-25 as a promising therapeutic target for lung cancer metastasis. Given that oxidative stress induces the overexpression of miR-25 and plays a critical role in cancer progression, this study establishes miR-25 as an intermediate between oxidative stress and lung cancer metastasis.</description><subject>Adaptor Proteins, Signal Transducing - genetics</subject><subject>Adaptor Proteins, Signal Transducing - metabolism</subject><subject>Apoptosis</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - genetics</subject><subject>Cell Proliferation - physiology</subject><subject>China</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Kinases</subject><subject>Lung cancer</subject><subject>Lung cancer, Non-small cell</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - pathology</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Mortality</subject><subject>Oxidative stress</subject><subject>Pathogenesis</subject><subject>Prostate</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Signal Transduction</subject><subject>Survival analysis</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Tumor proteins</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNks9v0zAUxyMEYlvhxhlZ4oLEQv0jTuLLpKpiMKlARcuBk_XqOKmnxB52sqn_AH83ztp1wImT33v--Pv8tV-SvCL4PSGcTykmYioKIgrKniSnRGQ0xUJkT48xxifJWQjXGOeMZuR5csIII3nkT5NfnfmWUo6W3nWu1wHNdduOWWtq7aE3zp6jz6Z5CMFW6MreQogZcjX64my66qBt0_uDi8E2aA5WaY82O7QG3-jexFq_1WgxW6_o9MdsiVamsdCO9SX02zvYvUie1dAG_fKwTpLvlx_W80_p4uvHq_lskapMiD6FHLBighCMs5qUpd7QrNRVlVFFSthwTkWh8lyJkmlVcFaVGRCywRwrXKmSsklysde9GTadrpS2vYdW3njTgd9JB0b-vWPNVjbuVuY5zmiUnSRvDwLe_Rx06GVngorWwWo3BEkpFwIXvMgi-uYf9NoNPvq-pzBnXOTskWqg1dLY2sW-ahSVsxwzwhkrx7bne0p5F4LX9fHKBMtxDOQ4BvIwBhF__afNI_zw7xF4twe2xlZwZ_5TTkdG1_BIUzw-DPsNoiXBqw</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Ning, Yong</creator><creator>Li, Yong</creator><creator>Lu, Zhongxin</creator><creator>Yan, Ge</creator><creator>Zheng, Chao</creator><creator>Liu, Shuiyi</creator><creator>Li, Xiaoyi</creator><creator>Jiang, Liyuan</creator><creator>Zhang, Tianzhu</creator><creator>Hu, Hui</creator><creator>Wu, Tangwei</creator><creator>Chen, Weiqun</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8838-1714</orcidid><orcidid>https://orcid.org/0000-0002-4628-2117</orcidid><orcidid>https://orcid.org/0000-0002-3365-0881</orcidid></search><sort><creationdate>2019</creationdate><title>miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway</title><author>Ning, Yong ; Li, Yong ; Lu, Zhongxin ; Yan, Ge ; Zheng, Chao ; Liu, Shuiyi ; Li, Xiaoyi ; Jiang, Liyuan ; Zhang, Tianzhu ; Hu, Hui ; Wu, Tangwei ; Chen, Weiqun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adaptor Proteins, Signal Transducing - genetics</topic><topic>Adaptor Proteins, Signal Transducing - metabolism</topic><topic>Apoptosis</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - genetics</topic><topic>Cell Proliferation - physiology</topic><topic>China</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Kinases</topic><topic>Lung cancer</topic><topic>Lung cancer, Non-small cell</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - pathology</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Mortality</topic><topic>Oxidative stress</topic><topic>Pathogenesis</topic><topic>Prostate</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Signal Transduction</topic><topic>Survival analysis</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Tumor proteins</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ning, Yong</creatorcontrib><creatorcontrib>Li, Yong</creatorcontrib><creatorcontrib>Lu, Zhongxin</creatorcontrib><creatorcontrib>Yan, Ge</creatorcontrib><creatorcontrib>Zheng, Chao</creatorcontrib><creatorcontrib>Liu, Shuiyi</creatorcontrib><creatorcontrib>Li, Xiaoyi</creatorcontrib><creatorcontrib>Jiang, Liyuan</creatorcontrib><creatorcontrib>Zhang, Tianzhu</creatorcontrib><creatorcontrib>Hu, Hui</creatorcontrib><creatorcontrib>Wu, Tangwei</creatorcontrib><creatorcontrib>Chen, Weiqun</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ning, Yong</au><au>Li, Yong</au><au>Lu, Zhongxin</au><au>Yan, Ge</au><au>Zheng, Chao</au><au>Liu, Shuiyi</au><au>Li, Xiaoyi</au><au>Jiang, Liyuan</au><au>Zhang, Tianzhu</au><au>Hu, Hui</au><au>Wu, Tangwei</au><au>Chen, Weiqun</au><au>Moorthy, Bhagavatula</au><au>Bhagavatula Moorthy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2019</date><risdate>2019</risdate><volume>2019</volume><issue>2019</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including metastasis. Our previous studies revealed that miR-25 promoted non-small-cell lung cancer (NSCLC) cell proliferation and suppressed cell apoptosis by directly targeting TP53 and MOAP1. In this work, we further explored the miR-25 expression in NSCLC patients in the Cancer Genome Atlas (TCGA) database and measured the miR-25 expression levels in the tissues of NSCLC patients and cell lines. miR-25 was overexpressed in both NSCLC tissues and cell lines. NSCLC patients who expressed a higher level of miR-25 exhibited worse overall survival than those with a lower level of miR-25. Overexpression of miR-25 enhanced NSCLC cell migration and invasion, while the inhibition of miR-25 exhibited the opposite effects. We identified the large tumor suppressor homology 2 (LATS2) as a new target gene of miR-25 in lung cancer. The effects of miR-25 on promoting NSCLC cell migration and invasion were at least partially due to activation of the Hippo signaling pathway. Additionally, miR-25 antagomir inhibited xenograft tumor growth and metastasis by the upregulation of LATS2. Taken together, our findings demonstrate that miR-25 contribute to lung cancer cell proliferation and metastasis by targeting the LATS2/YAP signaling pathway, which implicate miR-25 as a promising therapeutic target for lung cancer metastasis. Given that oxidative stress induces the overexpression of miR-25 and plays a critical role in cancer progression, this study establishes miR-25 as an intermediate between oxidative stress and lung cancer metastasis.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>31316723</pmid><doi>10.1155/2019/9719723</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-8838-1714</orcidid><orcidid>https://orcid.org/0000-0002-4628-2117</orcidid><orcidid>https://orcid.org/0000-0002-3365-0881</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1942-0900 |
ispartof | Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-14 |
issn | 1942-0900 1942-0994 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6604298 |
source | Wiley Online Library website; Publicly Available Content (ProQuest) |
subjects | Adaptor Proteins, Signal Transducing - genetics Adaptor Proteins, Signal Transducing - metabolism Apoptosis Biomarkers Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Cell cycle Cell growth Cell Line, Tumor Cell Proliferation - genetics Cell Proliferation - physiology China Gene expression Gene Expression Regulation, Neoplastic Genetic aspects Genomes Health aspects Humans Kinases Lung cancer Lung cancer, Non-small cell Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - pathology Medical prognosis Metastasis MicroRNA MicroRNAs - genetics MicroRNAs - metabolism Mortality Oxidative stress Pathogenesis Prostate Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - metabolism Signal Transduction Survival analysis Transcription Factors - genetics Transcription Factors - metabolism Tumor proteins Tumor Suppressor Proteins - genetics Tumor Suppressor Proteins - metabolism |
title | miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A13%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-25%20Promotes%20Cell%20Proliferation,%20Migration,%20and%20Invasion%20of%20Non-Small-Cell%20Lung%20Cancer%20by%20Targeting%20the%20LATS2/YAP%20Signaling%20Pathway&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Ning,%20Yong&rft.date=2019&rft.volume=2019&rft.issue=2019&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2019/9719723&rft_dat=%3Cgale_pubme%3EA603153388%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-a6a0c3911004f188eb248edd42c18ab55297c66c983ec753d84a11b050c0dc823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2250535963&rft_id=info:pmid/31316723&rft_galeid=A603153388&rfr_iscdi=true |